Overweight and obesity managementStatus:In developmentProgramme:NICE guidelineExpected publication date: 14 January 2025
Semaglutide for preventing major cardiovascular events in people with cardiovascular disease and living with overweight or obesity ID6441Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: TBC